Evidence map›Paper›PMID 29515782›Full record

ArticleOncotarget2018

Urokinase-derived peptide UP-7 suppresses tumor angiogenesis and metastasis through inhibition of FAK activation.

Hyun-Kyung Kim, Purevjargal Naidansuren, Seung Woo Lee, Rae-Kwon Kim, Su-Jae Lee, Suk Keun Lee, Yong-Kil Hong, Young Ae Joe

Open access · diamondAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Oncotarget, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.2field-weighted citation impact, top 50% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 4 citations in OpenAlex.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 3 institutions in 1 country.

Hyun-Kyung KimCancer Research Institute, College of Medicine, The Catholic University of Korea, Seoul, 06519, Republic of Korea.
Purevjargal NaidansurenCancer Research Institute, College of Medicine, The Catholic University of Korea, Seoul, 06519, Republic of Korea.
Seung Woo LeeCancer Research Institute, College of Medicine, The Catholic University of Korea, Seoul, 06519, Republic of Korea.
Rae-Kwon KimDepartment of Life Science, Research Institute for Natural Sciences, Hanyang University, Seoul, 04763, Republic of Korea.
Su-Jae LeeDepartment of Life Science, Research Institute for Natural Sciences, Hanyang University, Seoul, 04763, Republic of Korea.
Suk Keun LeeDepartment of Oral Pathology, College of Dentistry, Kangnung National University, Gangneung, Gangwon-do, 25457, Republic of Korea.
Yong-Kil HongCancer Research Institute, College of Medicine, The Catholic University of Korea, Seoul, 06519, Republic of Korea.
Young Ae JoeCancer Research Institute, College of Medicine, The Catholic University of Korea, Seoul, 06519, Republic of Korea.
Catholic University of Korea · KRGangneung–Wonju National University · KRHanyang University · KR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The recombinant kringle domain of urokinase (UK1) has been shown to inhibit angiogenesis and brain tumor growth

Indexed as

angiogenesis inhibitorbreast cancermetastasispeptideurokinase-type plasminogen activator

Identifiers

PMID29515782
PMCPMC5839413
OpenAlexW2783409518

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.